Acknowledgment
MAY, BROWN
The investigators thank the participants, their families, and caregivers for their extraordinary dedication to this research. The investigators also thank their collaborators on the scientific research teams at Massachusetts General Hospital, Brown University, the Providence VA Medical Center, Stanford, and Case Western Reserve University for their ongoing contributions to this incredible research. The investigators are also grateful for John Mislow, MD, PhD, who assisted with an early draft of this manuscript. From June 2004 to May 2009, the BrainGate pilot clinical trials were sponsored and directed by Cyberkinetics Neurotechnology Systems. In 2009, those original clinical trials and the subsequent trial (“BrainGate2”) have been conducted by academic institutions with grant support from the NIH, VA, and charitable foundations. All data reported herein have been previously reported to the independent institutional review boards and to the US FDA.Class of Evidence: 